Osteoarthritic synovial fibroblasts possess an increased level of tumor necrosis factor-receptor 55 (TNF-R55) that mediates biological activation by TNF-α

Journal of Rheumatology

Volumn 24, Issue 10, 1997, Pages 1985-1994

  Alaaeddine, Nada ^a   DiBattista, John A ^a   Pelletier, Jean Pierre ^a   Cloutier, Jean Marie ^c   Kiansa, Kayghobad ^a   Dupuis, Martine ^a   Martel Pelletier, Johanne ^b,d  

^a Department Medicine ^*

^b Louis Charles Simard Research Centre   (Canada)

^c St Luc Hospital

^d NOTRE DAME HOSPITAL   (Canada)

Author keywords

Osteoarthritis; Synovial fibroblasts; Tumor necrosis factor receptors; Tumor necrosis factor

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ANTIBODY SPECIFICITY; ARTICLE; CARTILAGE DEGENERATION; DRUG RECEPTOR BINDING; FIBROBLAST; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; INTERNALIZATION; LIGAND BINDING; OSTEOARTHRITIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; SYNOVIUM;

AGED; ANTIBODIES, BLOCKING; ANTIGENS, CD; CYCLOOXYGENASE 2; DINOPROSTONE; FIBROBLASTS; FLOW CYTOMETRY; HUMANS; ISOENZYMES; MEMBRANE PROTEINS; MIDDLE AGED; OSTEOARTHRITIS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RADIOLIGAND ASSAY; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; SYNOVIAL MEMBRANE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030847895     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. 2 production by human synovial cells. J Clin Invest 1986;77:645-8.
2. Saklatvala J: Tumour necrosis factor-α stimulates resorption and inhibits synthesis of proteoglycan in cartilage. Nature 1986;322:547-9.
3. Campbell IK, Piccoli DS, Roberts MJ, Muirden KD, Hamilton JA: Effects of tumor necrosis factor alpha and beta on resorption of human articular cartilage and production of plasminogen activator by human articular chondrocytes. Arthritis Rheum 1990;33:542-52.
4. Mitchell PG, Cheung HS: Tumor necrosis factor alpha and epidermal growth factor regulation of collagenase and stromelysin in adult porcine articular chondrocytes. J Cell Physiol 1991;149:132-40.
5. Chu CQ, Field M, Feldmann M, Maini RN: Localization of tumor necrosis factor α in synovial tissues and at the cartilage-pannus junction in patients with rheumatoid arthritis. Arthritis Rheum 1991;34:1125-32.
6. Feldmann M, Brennan FM, Chantry D, et al: Cytokine assays: Role in evaluation of the pathogenesis of autoimmunity. Immunol Rev 1991;119:105-23.
7. Chikanza IC, Roux-Lombard P, Dayer JM, Panayi GS: Tumor necrosis factor soluble receptors behave as acute phase reactants following surgery in patients with rheumatoid arthritis, chronic osteomyelitis and osteoarthritis. Clin Exp Immunol 1993;92:19-22.
8. Farahat MN, Yanni G, Poston R, Panayi GS: Cytokine expression in synovial membranes of patients with rheumatoid arthritis and osteoarthritis. Ann Rheum Dis 1993;52:870-5.
9. Corti A, Poiesi C, Merli S, Cassani G: Tumor necrosis factor (TNF) alpha quantification by ELISA and bioassay: Effects of TNF alpha-soluble TNF receptor (p55) complex dissociation during assay incubations. J Immunol Methods 1994;177:191-8.
10. Smith RA, Baglioni C: The active form of tumor necrosis factor is a trimer. J Biol Chem 1987;262:6951-4.
11. Brockhaus M, Schoenfeld HJ, Schlaeger EJ, Hunziker W, Lesslauer W, Loetscher H: Identification of two types of tumor necrosis factor receptors on human cells lines by monoclonal antibodies. Immunology 1990;87:3127-31.
12. Schall TJ, Lewis M, Koller KJ, et al: Molecular cloning and expression of a receptor for human tumor necrosis factor. Cell 1990;61:361-70.
13. Loetscher H, Pan YCE, Lahm HW, et al: Molecular cloning and expression of the human 55 kd tumor necrosis factor receptor. Cell 1990;61:351-9.
14. Smith CA, Davis T, Anderson D, et al: A receptor for tumor necrosis factor defines an unusual family of cellular and viral proteins. Science 1990;248:1019-23.
15. Tartaglia LA, Weber RF, Figari IS, Reynolds C, Palladino MA Jr, Goeddel DV: The two different receptors for tumor necrosis factor mediate distinct cellular responses. Immunology 1991;88:9292-6.
16. Kammermann JR, Kincaid SA, Rumph PF, Baird DK, Visco DM: Tumor necrosis factor-a (TNF-α) in canine osteoarthritis: Immunolocalization of TNF-α, stromelysin and TNF receptors in canine osteoarthritic cartilage. Osteoarthritis Cartilage 1996;4:23-34.
17. Loetscher H, Steinmetz M, Lesslauer W: Tumor necrosis factor: Receptors and inhibitors (review). Cancer Cells 1997;3:221-6.
18. Seckinger P, Isaaz S, Dayer JM: Purification and biologic characterization of specific tumor necrosis factor alpha inhibitor. J Biol Chem 1989;264:11966-73.
19. Engelmann H, Novick D, Wallach D: Two tumor necrosis factor-binding proteins purified from human urine. J Biol Chem 1990;265:1531-6.
20. Porteu F, Nathan C: Shedding of tumor necrosis factor receptors by activated human neutrophils. J Exp Med 1990;172:599-607.
21. Crowe PD, Walter BN, Mohler KM, Otten-Evans C, Black RA, Ware CF: A metalloprotease inhibitor blocks shedding of the 80-kD TNF receptor and TNF processing in T lymphocytes. J Exp Med 1995;181:1205-10.
22. Roux-Lombard P, Punzi L, Hasler F, et al: Soluble tumor necrosis factor receptors in human inflammatory synovial fluids. Arthritis Rheum 1993;36:485-9.
23. Cope AP, Aderka D, Doherty M, et al: Increased levels of soluble tumor necrosis factor receptors in the sera and synovial fluid of patients with rheumatic diseases. Arthritis Rheum 1992;35:1160-9.
24. Altman R, Asch E, Bloch D, et al: Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Arthritis Rheum 1986;29:1039-49.
25. Sadouk M, Pelletier JP, Tardif G, Kiansa K, Cloutier JM, Martel-Pelletier J: Human synovial fibroblasts coexpress interleukin-1 receptor type I and type II mRNA: The increased level of the interleukin-1 receptor in osteoarthritic cells is related to an increased level of the type 1 receptor. Lab Invest 1995;73:347-55.
26. Martel-Pelletier J, McCollum R, DiBattista JA, et al: The interleukin-1 receptor in normal and osteoarthritic human articular chondrocytes. Identification as the type I receptor and analysis of binding kinetics and biologic function. Arthritis Rheum 1992;35:530-40.
27. McPherson GA: A practical computer-based approach to the analysis of radioligand binding experiments. Comput Methods Programs Biomed 1983;17:107-13.
28. 2 synthesis by a selective COX-2 inhibitor (abstr). Inflamm Res 1995;144:8273.
29. Towbin H, Staehelin T, Gordon J: Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proc Natl Acad Sci USA 1979;76:4350-4.
30. Martel-Pelletier J, Mineau F, Jolicoeur FC, Pelletier JP: Modulation of TNFsR55 and TNFsR75 by cytokines and growth factors in human synovial fibroblasts. J Rheumatol 1995;(suppl 43)22:115-9.
31. Haraoui B, Pelletier JP, Cloutier JM, Faure MP, Martel-Pelletier J: Synovial membrane histology and immunopathology in rheumatoid arthritis and osteoarthritis. In vivo effects of anti-rheumatic drugs. Arthritis Rheum 1991;34:153-63.
32. Lindblad S, Hedfors E: Arthroscopic and immunohistologic characterization of knee joint synovitis in osteoarthritis. Arthritis Rheum 1987;30:1081-8.
33. Pelletier JP, McCollum R, Cloutier DIM, Martel-Pelletier J: Synthesis of metalloproteases and interleukin 6 (IL-6) in human osteoarthritic synovial membrane is an IL-1 mediated process. J Rheumatol 1995;22:109-14.
34. Vignon E, Balblanc JC, Mathieu P, Louisot P, Richard M: Metalloprotease activity, phospholipase A, activity and cytokine concentration in osteoarthritis synovial fluids. Osteoarthritis Cartilage 1993;1:115-20.
35. Thoma B, Grell M, Pfizenmaier K, Scheurich P: Identification of a 60-kD tumor necrosis factor (TNF) receptor as the major signal transducing component in TNF responses. J Exp Med 1990;172:1019-23.
36. Menegazzi R, Cramer R, Patriarca P, Scheurich P, Dri P: Evidence that tumor necrosis factor a (TNF)-induced activation of neutrophil respiratory burst on biologic surfaces is mediated by the p55 TNF receptor. Blood 1994;84:287-93.
37. Trentin L, Zambello R, Bulian P, et al: Tumour-infiltrating lymphocytes bear the 75 kDa tumor necrosis factor receptor. Br J Cancer 1995:71:240-5.
38. Heller RA, Song K, Fan N, Chang DJ: The p70 tumor necrosis factor receptor mediates cytotoxicity. Cell 1992;70:47-56.
39. Scheurich P, Thoma B, Ucer U, Pfizenmaier K: Immunoregulatory activity of recombinant human tumor necrosis factor (TNF)-alpha: Induction of TNF receptors on human T cells and TNF-alpha-mediated enhancement of T cell responses. J Immunol 1987;138:1786-90.
40. Deleuran BW, Chu CQ, Field M, et al: Localization of tumor necrosis factor receptors in the synovial tissue and cartilage-pannus junction in patients with rheumatoid arthritis. Arthritis Rheum 1992;35:1170-8.
41. Tartaglia LA, Pennica D, Goeddel DV: Ligand passing: The 75-kDa tumor necrosis factor (TNF) receptor recruits TNF for signaling by the 55-kDa TNF receptor. J Biol Chem 1993;268:18542-8.
42. Joosten LAB, Helsen MMA, Van de Loo FAJ, van den Berg WB: Anticytokine treatment of established type II collagen-induced arthritis in DBA/1 mice. Arthritis Rheum 1996;39:797-809.
43. Gammeltoft S, Kahn CR: Hormone signaling via membrane receptors. In: Besser M, Burger HG, Jameson JL, et al, eds. Endocrinology, 3rd ed. Philadelphia: WB Saunders, 1995:17-65.
44. DiBattista JA, Martel-Pelletier J, Wosu LO, Sandor T, Antakly T, Pelletier JP: Glucocorticoid receptor mediated inhibition of interleukin-1 stimulated neutral metalloprotease synthesis in normal human chondrocytes. J Clin Endocrinol Metab 1991;72:316-26.
45. Grell M, Douni E, Wajant H, et al: The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor. Cell 1995;83:793-802.